Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphocytic Bronchiolitis”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Early research (Phase 1)Temporarily pausedNCT05993611
What this trial is testing

Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Chronic Graft Versus Host DiseaseHematologic and Lymphocytic DisorderSteroid Refractory Graft Versus Host Disease
City of Hope Medical Center 27
Testing effectiveness (Phase 2)Study completedNCT00077922
What this trial is testing

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphocyticChronic
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Not applicableUnknownNCT05692713
What this trial is testing

Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)

Who this might be right for
Chronic Graft-versus-Host-DiseaseAllogeneic Hematopoietic Stem Cell TransplantationLeukemia+2 more
University of British Columbia 320
Early research (Phase 1)Ended earlyNCT03759184
What this trial is testing

Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia

Who this might be right for
LeukemiaLymphocyticChronic+1 more
National Cancer Institute (NCI) 1
Post-approval studies (Phase 4)Study completedNCT01109160
What this trial is testing

Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation

Who this might be right for
Lymphocytic Bronchi(Oli)Tis Post-lung Transplantation
KU Leuven 15
Testing effectiveness (Phase 2)Study completedNCT00280241
What this trial is testing

Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
University of Pittsburgh 65
Testing effectiveness (Phase 2)Ended earlyNCT01600053
What this trial is testing

Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Thomas Kipps 11
Early research (Phase 1)Study completedNCT00742144
What this trial is testing

Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular
GlaxoSmithKline 6
Testing effectiveness (Phase 2)Study completedNCT02388048
What this trial is testing

Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphoblastic, Chronic
Gruppo Italiano Malattie EMatologiche dell'Adulto 19
Early research (Phase 1)Study completedNCT01149668
What this trial is testing

A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer

Who this might be right for
LymphomaNon-Hodgkin's LymphomaHodgkin Disease+3 more
Pharmacyclics LLC. 7
Testing effectiveness (Phase 2)Study completedNCT04716075
What this trial is testing

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

Who this might be right for
Chronic Lymphocytic LeukemiaChronic Graft-versus-host-diseaseMantle Cell Lymphoma+2 more
Polish Lymphoma Research Group 29
Large-scale testing (Phase 3)Looking for participantsNCT01804686
What this trial is testing

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+4 more
Janssen Research & Development, LLC 700
Early research (Phase 1)Study completedNCT01991184
What this trial is testing

GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

Who this might be right for
Lymphocytic Leukemia, Chronic, Diffuse Large B-Cell Lymphoma
Genentech, Inc. 24
Not applicableTemporarily pausedNCT04843345
What this trial is testing

Sjogren's Lung Study

Who this might be right for
Sjogren's SyndromeInterstitial Lung DiseasePrimary Pulmonary Lymphoma (Disorder)+5 more
Stanford University 500
Testing effectiveness (Phase 2)Study completedNCT01994382
What this trial is testing

Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL

Who this might be right for
Follicular Lymphoma (FL/Indolent NHL)Aggressive NHL (a NHL)Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)+2 more
Alexion Pharmaceuticals, Inc. 260
Testing effectiveness (Phase 2)Study completedNCT00328198
What this trial is testing

Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Genzyme, a Sanofi Company 86
Early research (Phase 1)Study completedNCT01680991
What this trial is testing

Obinutuzumab in Chinese Participants With CD20+ Malignant Disease

Who this might be right for
Lymphocytic Leukemia, Chronic, Diffuse Large B-cell Lymphoma, Follicular Lymphoma
Hoffmann-La Roche 48
Testing effectiveness (Phase 2)UnknownNCT00800943
What this trial is testing

Study of Subcutaneous Campath-1H in Patients With B-Cell CLL and Residual Disease After Chemotherapy

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia Research Consortium 31
Early research (Phase 1)WithdrawnNCT02743546
What this trial is testing

Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+1 more
Janssen Research & Development, LLC
Load More Results